Kaloun, El Bachir,Bedjeguelal, Karim,Rabot, Remi,Kruczynski, Anna,Schmitt, Philippe,Perez, Michel,Rahier, Nicolas
申请号：
AU2012210467
公开号：
AU2012210467B2
申请日:
2012.01.27
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture； as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease； to the use of same as a kinase inhibitor； to the pharmaceutical compositions comprising same； and to methods for the preparation of same.
